|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thoracic Imaging |
1 From the Departments of Diagnostic Radiology and Organ Imaging (K.T.W., G.E.A., E.H.Y.Y., A.T.A.), Medicine and Therapeutics (D.S.C.H., N.L., A.W., C.B.L., J.J.Y.S.), Accident and Emergency Medicine (T.H.R., P.C.), and Surgery (S.S.C.C.), Prince of Wales Hospital, Chinese University of Hong Kong, 30-32 Ngan Shing St, Shatin, Hong Kong SAR. Received April 15, 2003; revision requested April 17; revision received April 22; accepted April 29. Address correspondence to K.T.W. (e-mail: wongkatakjeffrey@hotmail.com).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: Chest radiographs obtained at clinical presentation and during treatment in 138 patients with confirmed SARS (66 men, 72 women; mean age, 39 years; age range, 2083 years) were assessed. Radiographic appearances of pulmonary parenchymal abnormality, distribution, and extent of involvement on initial chest radiographs were documented. Recognizable patterns of radiographic progression were determined by comparing the overall mean percentage of lung involvement for each patient on serial radiographs.
RESULTS: Initial chest radiographs were abnormal in 108 of 138 (78.3%) patients and showed air-space opacity. Lower lung zone (70 of 108, 64.8%) and right lung (82 of 108, 75.9%) were more commonly involved. In most patients, peripheral lung involvement was more common (81 of 108, 75.0%). Unifocal involvement (59 of 108, 54.6%) was more common than multifocal or bilateral involvement. No cavitation, lymphadenopathy, or pleural effusion was demonstrated. Four patterns of radiographic progression were recognized: type 1 (initial radiographic deterioration to peak level followed by radiographic improvement) in 97 of 138 patients (70.3%), type 2 (fluctuating radiographic changes) in 24 patients (17.4%), type 3 (static radiographic appearance) in 10 patients (7.3%), and type 4 (progressive radiographic deterioration) in seven patients (5.1%). Initial focal air-space opacity in 44 of 59 patients (74.6%) progressed to unilateral multifocal or bilateral involvement during treatment.
CONCLUSION: Predominant peripheral location; common progression pattern from unilateral focal air-space opacity to unilateral multifocal or bilateral involvement during treatment; and lack of cavitation, lymphadenopathy, and pleural effusion are the more distinctive radiographic findings of SARS.
© RSNA, 2003
Index terms: Lung, radiography, 68.11 Pneumonia, acute interstitial, 68.21 Severe acute respiratory syndrome
| INTRODUCTION |
|---|
|
|
|---|
Anthony V. Proto, MD, Editor
In early March 2003, there was an outbreak of atypical pneumonia in Hong Kong. The World Health Organization (WHO) defined the illness as severe acute respiratory syndrome (SARS). At the time of writing this article, there have been 1,059 reported cases in Hong Kong and more than 2,890 cases worldwide (1), including 32 deaths in Hong Kong related to the illness.
At our institution, over 200 confirmed cases of SARS have been treated (2). Imaging plays a crucial role in diagnosis and in monitoring of disease progress during medical treatment. From our experience, the radiographic appearances of SARS at the time of initial presentation are variable, ranging from normal to widespread opacification. In addition, patients show different radiologic progression during treatment.
Because the role of imaging is central to the diagnosis and the care of the patients, radiographers and radiologists should be aware of the radiographic appearances of this disease and the infection-control guidelines to prevent transmission of the disease. The purpose of our study was to retrospectively evaluate the radiographic appearances and patterns of progression in patients with SARS.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
The frontal chest radiographs obtained at clinical presentation and at follow-up during treatment were retrospectively reviewed in consensus by three radiologists (K.T.W., G.E.A., H.Y.Y.) who were unaware of the clinical progress of the subjects. Each lung was divided into three zones: upper, middle, and lower. Each zone spanned one-third of the craniocaudal distance of the lung on the frontal radiograph and was evaluated separately.
The observers assessed the presence, appearances, distribution, and size of lung parenchymal abnormalities on each chest radiograph in all subjects. The appearances were categorized as follows: air-space shadow, reticular shadow, nodular shadow, or mass. The anatomic distribution was noted to be central if the abnormality predominantly involved the medial half of the zone and peripheral if it predominantly involved the lateral half. The size of the lesion was assessed by visually estimating the percentage area occupied in each zone on each side to determine the overall mean percentage of involvement by averaging the percentage involvement of the six lung zones. Associated findings, in particular the presence of cavitation, lymphadenopathy, and pleural effusion, were also assessed.
Serial frontal chest radiographs obtained during treatment were also retrospectively reviewed by the same radiologists in consensus. All subjects included in this study underwent serial follow-up chest radiography for at least 14 days (unless deceased). For each follow-up radiograph, the extent of lung parenchymal involvement was assessed by using the same method as for the radiograph obtained at initial clinical presentation. Follow-up radiographs were obtained daily during the hospital stay. All subjects were given a combination of ribavirin (Derbin BLC, United Kingdom) (an antiviral agent, administered orally; initial dose of 2.4 g followed by 1.2 g three times daily) and corticosteroid (prednisolone; Clonmel Healthcare, Ireland) (0.51.0 mg per kilogram of body weight per day; ) for treatment. The steroid methylprednisolone (Solu-medrol; Pharmacia Upjohn, Belgium) was administered intravenously in pulsed fashion (0.5 g for three consecutive days) to 107 subjects whose clinical condition so indicated.
Data Analysis
The radiographic patterns at the time of clinical presentation in all 138 subjects, as assessed on initial chest radiographs, were analyzed and categorized as normal or unifocal, unilateral multifocal, or bilateral multifocal abnormalities. The distribution of lung parenchymal involvement in terms of central or peripheral involvement and the zones involved were noted. We determined if there were recognizable patterns of radiographic progression by comparing the overall percentage of lung involvement for each subject on serial radiographs.
| RESULTS |
|---|
|
|
|---|
Distribution of Abnormalities at Presentation
The location and appearance of lung opacities on initial radiographs are shown in Tables 2 and 3, respectively. The right lung (82 of 108 subjects, 75.9%) was involved in more subjects than the left (67 of 108, 62.0%). The disease showed a predilection for the lower zone (70 of 108, 64.8%). Involvement of peripheral lung parenchyma (81 of 108, 75.0%) (Fig 1) was more common than a mixed peripheral and central pattern (14 of 108, 13.0%) or a central pattern (13 of 108, 12.0%) at the time of presentation. Unifocal involvement (59 of 108, 54.6%) was slightly more common than multifocal involvement (49 of 108, 45.4%). Bilateral disease was present in 41 (38.0%) subjects. At presentation, the overall mean lung involvement was 4.7% (range, 0.8%63.3%).
|
|
|
At review of follow-up radiographs, we were able to identify four patterns of radiographic progression (Table 4, Fig 2): type 1, initial radiographic deterioration to peak level, followed by radiographic improvement, with maximum difference in overall mean lung involvement greater than 25%; type 2, fluctuating radiographic changes with at least two radiographic peaks and an intervening trough, which differed by more than 25% for overall mean lung involvement; type 3, static radiographic changes with no discernible radiographic peak or change in overall mean lung involvement of less than 25% for more than 10 days; and type 4, progressive radiographic deterioration.
|
|
|
|
|
Confluent air-space opacities diffusely involving both lungs, compatible with acute respiratory distress syndrome, were observed in 11 of 138 subjects (8.0%) during the course of the disease (Fig 4); this occurred almost exclusively in subjects with poor clinical outcome (six died and five required prolonged assisted ventilation at the end of the study period).
|
| DISCUSSION |
|---|
|
|
|---|
On the basis of our results, air-space opacification is the pattern seen on chest radiographs in patients with SARS. All but one of 138 subjects showed air-space opacification of varying extent and distribution at some stage of the disease. In one subject, the initial and early-progress radiographs were normal and the diagnosis was made with the aid of thin-section CT of thorax. The CT scans in this subject showed a small (approximately 2-cm) area of ground-glass opacification with intralobular interstitial and interlobular septal thickening in the posterior costophrenic recess of the right lung. We have recently reported the thin-section CT findings in patients with SARS (6).
The peripheral location of air-space opacification was another common radiographic feature of SARS in our study. The opacities occupied a peripheral or mixed peripheral and central location in 88% of subjects. Important absent findings included the lack of cavitation, lymphadenopathy, or pleural effusion.
The radiographic appearance of peripheral air-space opacities in SARS is indistinguishable from other causes of atypical pneumonia, such as Mycoplasma, Chlamydia, and Legionella (7,8), and overlap with other types of viral pneumonia in adults (9). Since imaging alone cannot help differentiate SARS from other diseases, the clinical manifestation is indispensable for diagnosis. The presence of characteristic clinical features, including high fever (temperature > 38°C), chills, rigor, myalgia, and laboratory findings such as leukopenia and thrombocytopenia in patients with recent exposure, are very suggestive of SARS. The presence of an air-space opacity on chest radiographs has been as helpful in confirmation of the diagnosis.
Radiographic progression to unilateral multifocal or bilateral involvement occurred in most subjects with unilateral focal air-space opacity on the initial chest radiograph obtained during treatment with a combination of an antiviral agent and corticosteroids. We found that only a small percentage (7.2%) of subjects with SARS showed a static radiographic appearance (type 3 pattern) for most of the time during treatment. On the other hand, progressive radiographic deterioration despite medical treatment seems to be associated with poor prognosis, with all deaths in our series occurring in patients with the type 4 pattern.
There are some limitations to our early study: (a) The subjects in this study were a heterogeneous group, and we have not taken into account the severity of clinical symptoms and clinical outcome. (b) Visual estimation of the percentage of lung involvement may appear to be subjective; however, in our opinion this appears to be the most practical method in real life, in an epidemic crisis in which it is not possible to design detailed computer-based models at short notice. (c) A frontal radiograph alone may not be accurate in helping identify central versus peripheral lesions; however, in patients who underwent thin-section CT, this localization proved to be accurate (6). (d) This report does not deal with clinical and radiologic comparison, particularly the timing and type of treatment regimen and the timing of the radiographic response. It also does not include evaluation of any outcome indicators. Such an evaluation requires detailed clinical, immunologic, and statistical analyses, which may be possible when more data and experience become available.
In conclusion, SARS has become a global health hazard and its high infectivity is alarming. Imaging plays an important role in the diagnosis and monitoring of response to therapy. The predominant peripheral location; common progression pattern from unilateral focal air-space opacity to unilateral multifocal or bilateral involvement during treatment; and lack of cavitation, lymphadenopathy, and pleural effusion are the more distinctive radiographic findings of this potentially lethal disease.
| FOOTNOTES |
|---|
Abbreviations: SARS = severe acute respiratory syndrome, WHO = World Health Organization
Author contributions: Guarantor of integrity of entire study, A.T.A.; study concepts, A.T.A., K.T.W., G.E.A., S.S.C.C., J.J.Y.S.; study design, A.T.A., K.T.W., G.E.A.; literature research, A.T.A., K.T.W., G.E.A.; experimental studies, K.T.W., D.S.C.H., N.L., A.W., C.B.L., T.H.R., P.C., J.J.Y.S., S.S.C.C.; data acquisition, K.T.W., G.E.A., D.S.C.H., N.L., E.H.Y.Y., A.W., C.B.L., T.H.R., P.C.; data analysis/interpretation, K.T.W., G.E.A., A.T.A.; manuscript preparation and editing, K.T.W., G.E.A., A.T.A., D.S.C.H.; manuscript definition of intellectual content, K.T.W., G.E.A., A.T.A., J.J.Y.S., D.S.C.H., P.C.; manuscript revision/review, K.T.W., A.T.A., G.E.A., D.S.C.H., P.C.; manuscript final version approval, K.T.W., A.T.A., D.S.C.H., J.J.Y.S.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. W. Chu, A. M. Li, A. W. H. Ng, H.-k. So, W. W. M. Lam, K. L. Lo, M.-c. A. Yeung, Y.-s. Yau, W.-k. Chiu, C.-w. Leung, et al. Thin-Section CT 12 Months After the Diagnosis of Severe Acute Respiratory Syndrome in Pediatric Patients. Am. J. Roentgenol., June 1, 2006; 186(6): 1707 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Antonio, C. G. C. Ooi, K. T. Wong, E. L. H. Tsui, J. S. W. Wong, A. N. L. Sy, J. Y. H. Hui, C. Y. Chan, H. Y. H. Huang, Y. F. Chan, et al. Radiographic-Clinical Correlation in Severe Acute Respiratory Syndrome: Study of 1373 Patients in Hong Kong Radiology, December 1, 2005; 237(3): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hui, K. T. Wong, F. W. Ko, L. S. Tam, D. P. Chan, J. Woo, and J. J.Y. Sung The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors Chest, October 1, 2005; 128(4): 2247 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Ong, A. W.-K. Ng, L. S.-U Lee, G. Kaw, S.-K. Kwek, M. K.-S. Leow, and A. Earnest 1-Year Pulmonary Function and Health Status in Survivors of Severe Acute Respiratory Syndrome Chest, September 1, 2005; 128(3): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chang, C.-J. Yu, S.-C. Chang, J. R. Galvin, H.-M. Liu, C.-H. Hsiao, P.-H. Kuo, K.-Y. Chen, T. J. Franks, K.-M. Huang, et al. Pulmonary Sequelae in Convalescent Patients after Severe Acute Respiratory Syndrome: Evaluation with Thin-Section CT Radiology, September 1, 2005; 236(3): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
F W T Cheng, P C Ng, W K Chiu, W C W Chu, A M Li, K L Lo, E K L Hon, E A S Nelson, T F Leung, W H Ng, et al. A case-control study of SARS versus community acquired pneumonia Arch. Dis. Child., July 1, 2005; 90(7): 747 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
D S Hui, G M Joynt, K T Wong, C D Gomersall, T S Li, G Antonio, F W Ko, M C Chan, D P Chan, M W Tong, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors Thorax, May 1, 2005; 60(5): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Griffith, G. E. Antonio, S. M. Kumta, D. S. C. Hui, J. K. T. Wong, G. M. Joynt, A. K. L. Wu, A. Y. K. Cheung, K. H. Chiu, K. M. Chan, et al. Osteonecrosis of Hip and Knee in Patients with Severe Acute Respiratory Syndrome Treated with Steroids Radiology, April 1, 2005; 235(1): 168 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Antonio, K. T. Wong, E. L. H. Tsui, D. P. N. Chan, D. S. C. Hui, A. W. H. Ng, K. K. Shing, E. H. Y. Yuen, J. C. K. Chan, and A. T. Ahuja Chest Radiograph Scores as Potential Prognostic Indicators in Severe Acute Respiratory Syndrome (SARS) Am. J. Roentgenol., March 1, 2005; 184(3): 734 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Y. Lai, H. Deif, E. A. LaMere, D. H. Pham, B. Wolff, S. Ward, B. Mederski, and M. R. Loutfy Severe Acute Respiratory Syndrome: Quantitative Assessment from Chest Radiographs with Clinical and Prognostic Correlation Am. J. Roentgenol., January 1, 2005; 184(1): 255 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.W. Tsang, G.C. Ooi, and P.L. Ho Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt? Eur. Respir. J., December 1, 2004; 24(6): 1025 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. C. Hui, K. T. Wong, G. E. Antonio, N. Lee, A. Wu, V. Wong, W. Lau, J. C. Wu, L. S. Tam, L. M. Yu, et al. Severe Acute Respiratory Syndrome: Correlation between Clinical Outcome and Radiologic Features Radiology, November 1, 2004; 233(2): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Ko, T.-Y. Lee, C.-C. Huang, Y.-F. Cheng, S.-H. Ng, Y.-L. Kuo, M.-C. Lin, J.-W. Liu, K. D. Yang, M.-C. Chen, et al. Severe Acute Respiratory Syndrome: Prognostic Implications of Chest Radiographic Findings in 52 Patients Radiology, October 1, 2004; 233(1): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
K-C. Ong, A.W-K. Ng, L.S-U. Lee, G. Kaw, S-K. Kwek, M.K-S. Leow, and A. Earnest Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome Eur. Respir. J., September 1, 2004; 24(3): 436 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Liu, Y.-T. Lu, M.-J. Peng, P.-J. Chen, R.-L. Lin, C.-L. Wu, and H.-T. Kuo Clinical and Laboratory Features of Severe Acute Respiratory Syndrome Vis-A-Vis Onset of Fever Chest, August 1, 2004; 126(2): 509 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. D Parashar and L. J Anderson Severe acute respiratory syndrome: review and lessons of the 2003 outbreak Int. J. Epidemiol., August 1, 2004; 33(4): 628 - 634. [Full Text] [PDF] |
||||
![]() |
H.-H. Hsu, C. Tzao, C.-P. Wu, W.-C. Chang, C.-L. Tsai, H.-J. Tung, and C.-Y. Chen Correlation of High-Resolution CT, Symptoms, and Pulmonary Function in Patients During Recovery From Severe Acute Respiratory Syndrome Chest, July 1, 2004; 126(1): 149 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
D S C Hui, M C H Chan, A K Wu, and P C Ng Severe acute respiratory syndrome (SARS): epidemiology and clinical features Postgrad. Med. J., July 1, 2004; 80(945): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Wan, H.-P. Kuo, Y.-H. Tsai, Y.-K. Wu, C.-H. Wang, C.-Y. Liu, K.-C. Kao, and S.-F. Ko Eight Cases of Severe Acute Respiratory Syndrome Presenting as Round Pneumonia Am. J. Roentgenol., June 1, 2004; 182(6): 1567 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Hsieh, W. P. Chan, J. C.-W. Chien, W.-S. Lee, M.-S. Yao, W.-M. Choi, C.-Y. Chen, and C. Yu Radiographic Appearance and Clinical Outcome Correlates in 26 Patients with Severe Acute Respiratory Syndrome Am. J. Roentgenol., May 1, 2004; 182(5): 1119 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G M-K Tse, K-F To, P K-S Chan, A W I Lo, K-C Ng, A Wu, N Lee, H-C Wong, S-M Mak, K-F Chan, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) J. Clin. Pathol., March 1, 2004; 57(3): 260 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Paul, H. Roberts, J. Butany, T. Chung, W. Gold, S. Mehta, E. Konen, A. Rao, Y. Provost, H. H. Hong, et al. Radiologic Pattern of Disease in Patients with Severe Acute Respiratory Syndrome: The Toronto Experience RadioGraphics, March 1, 2004; 24(2): 553 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Joynt, G. E. Antonio, P. Lam, K. T. Wong, T. Li, C. D. Gomersall, and A. T. Ahuja Late-Stage Adult Respiratory Distress Syndrome Caused by Severe Acute Respiratory Syndrome: Abnormal Findings at Thin-Section CT Radiology, February 1, 2004; 230(2): 339 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Muller, G. C. Ooi, P. L. Khong, L. J. Zhou, K. W. T. Tsang, and S. Nicolaou High-Resolution CT Findings of Severe Acute Respiratory Syndrome at Presentation and After Admission Am. J. Roentgenol., January 1, 2004; 182(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bitar, W. J. Weiser, M. Avendano, P. Derkach, D. E. Low, and D. Muradali Chest Radiographic Manifestations of Severe Acute Respiratory Syndrome in Health Care Workers: The Toronto Experience Am. J. Roentgenol., January 1, 2004; 182(1): 45 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Parmar, T. C. C. Lim, J. S.-K. Goh, J. T. Tan, Y. Y. Sitoh, and F. Hui Providing Optimal Radiology Service in the Severe Acute Respiratory Syndrome Outbreak: Use of Mobile CT Am. J. Roentgenol., January 1, 2004; 182(1): 57 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S.M. Peiris, K. Y. Yuen, A. D.M.E. Osterhaus, and K. Stohr The Severe Acute Respiratory Syndrome N. Engl. J. Med., December 18, 2003; 349(25): 2431 - 2441. [Full Text] [PDF] |
||||
![]() |
D.A. Groneberg, L. Zhang, T. Welte, P. Zabel, and K.F. Chung Severe acute respiratory syndrome: global initiatives for disease diagnosis QJM, November 1, 2003; 96(11): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. C. Ooi, P. L. Khong, J. C. M. Ho, B. Lam, W. M. Wong, W. C. Yiu, P. C. Wong, C. F. Wong, K. N. Lai, and K. W. T. Tsang Severe Acute Respiratory Syndrome: Radiographic Evaluation and Clinical Outcome Measures Radiology, November 1, 2003; 229(2): 500 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
N L Muller and J M FitzGerald Severe acute respiratory syndrome (SARS) Thorax, November 1, 2003; 58(11): 919 - 919. [Full Text] [PDF] |
||||
![]() |
C. G. C. Ooi, P. L. Khong, B. Lam, J. C. M. Ho, W. C. Yiu, W.-M. Wong, T. Wang, P. L. Ho, P. C. Wong, R. H. Chan, et al. Severe Acute Respiratory Syndrome: Relationship between Radiologic and Clinical Parameters Radiology, November 1, 2003; 229(2): 492 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
Radiographic Appearance of SARS Journal Watch Gastroenterology, September 30, 2003; 2003(930): 12 - 12. [Full Text] |
||||
![]() |
C.C. T. Lim, J. S. K. Goh, H. Parmar, Y. Y. Sitoh, J. T. Tan, and F. Hui CT and Picture Archiving and Communication Systems: Radiology Response to the SARS Outbreak [letter] Radiology, September 1, 2003; 228(3): 901 - 901. [Full Text] [PDF] |
||||
![]() |
|